BridgeBio Pharma, Inc.
BBIO
$45.95
$1.142.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 40.01% | -20.63% | 155.74% | -40.52% | -13.84% |
| Total Receivables | -33.31% | 2,341.02% | 887.87% | -27.58% | -99.72% |
| Inventory | 362.24% | -- | -- | -- | -- |
| Prepaid Expenses | 70.85% | 3.50% | 7.54% | 1.66% | 1.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 65.81% | -15.68% | -97.43% | 6.81% | 106,319.08% |
| Total Current Assets | 31.23% | -3.54% | 62.11% | -27.86% | -21.34% |
|
|
|||||
| Total Current Assets | 31.23% | -3.54% | 62.11% | -27.86% | -21.34% |
| Net Property, Plant & Equipment | -11.33% | 8.50% | -15.60% | -11.50% | -12.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.15% | 16.20% | -2.44% | -2.38% | -2.32% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.01% | -8.72% | -10.33% | 7.34% | -8.78% |
| Total Assets | 22.52% | -4.10% | 38.25% | -16.29% | -6.47% |
|
|
|||||
| Total Accounts Payable | -5.05% | 186.18% | -28.03% | -26.28% | 283.38% |
| Total Accrued Expenses | 25.81% | -16.78% | 18.51% | 16.15% | -17.67% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -8.20% | 15.60% | -2.04% | -0.50% | 1.74% |
| Total Finance Division Other Current Liabilities | -6.70% | -0.49% | -2.16% | -22.92% | -5.50% |
| Total Other Current Liabilities | -6.70% | -0.49% | -2.16% | -22.92% | -5.50% |
| Total Current Liabilities | 15.61% | -1.49% | 10.91% | 3.61% | -5.03% |
|
|
|||||
| Total Current Liabilities | 15.61% | -1.49% | 10.91% | 3.61% | -5.03% |
| Long-Term Debt | 0.08% | 7.36% | 0.12% | 0.10% | 0.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.11% | 4.66% | -19.49% | -17.37% | -14.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 60.95% | 3.76% | 2,512.46% | 8.93% | -14.84% |
| Total Liabilities | 13.42% | 6.03% | 26.21% | 0.37% | -0.52% |
|
|
|||||
| Common Stock & APIC | 2.19% | 1.85% | 1.44% | 1.35% | 1.65% |
| Retained Earnings | -5.57% | -5.41% | -9.36% | -6.07% | -2.83% |
| Treasury Stock & Other | 0.00% | -17.56% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -8.46% | -12.30% | -19.35% | -12.53% | -4.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.46% | -12.30% | -19.35% | -12.53% | -4.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.97% | -5.46% | -10.74% | 6.44% | -14.51% |
| Total Equity | -8.53% | -12.42% | -19.63% | -12.60% | -4.36% |
|
|
|||||